8 November 2016 – Craneware plc (AIM: CRW.L), the leader in Value Cycle solutions for the US healthcare market, will be holding its Annual General Meeting today at 10am. At the meeting, Keith Neilson, CEO of the Company, will make the following statement:
“We continue to see positive results in the first few months of the current fiscal year. In September we announced the move back into double-digit revenue and adjusted EBITDA growth. With the impact of sales made during FY16 starting to contribute to revenue, combined with our sales pipeline and activity, we see that momentum continuing in the current year.
“The US healthcare market continues its evolution towards value-based care with a critical dependency on accurate financial and operating data. We are investing in our Value Cycle product suite to ensure we have the solutions to provide hospitals with tools that deliver insight into these areas of their operations, expanding our market opportunity and increasing our strategic value within our market.
“2017 will see some exciting developments for Craneware with the launch of Trisus Claims Informatics, the first product to be launched on our newly developed cloud-based Trisus Enterprise Value Platform; followed shortly thereafter by the launch of Trisus Patient Payment, a new fourth gateway product, operating within the patient access and engagement area.
“We are also making good progress within our newly formed Group business, Craneware Healthcare Intelligence, which is focused on the development of cost analytics software for the US healthcare industry.
“With our expanded offering and market opportunity, high levels of revenue visibility and favourable market backdrop, we believe we are just at the start of a long-term growth trajectory and are confident in the future success of Craneware.”
For further information, please contact:
- +44 (0)20 7418 8900
- Dan Webster
- Adrian Trimmings
- George Sellar
- +44 (0)208 004 4218
- Caroline Forde
- Hilary Buchanan
- Robyn McConnachie
Craneware enables healthcare providers to improve margins and enhance patient outcomes so they can continue to provide quality outcomes for all.
Craneware is the leader in automated value cycle solutions that help US healthcare provider organisations discover, convert and optimise assets to achieve best clinical outcomes and financial performance. Founded in 1999, Craneware has its headquarters in Edinburgh, Scotland with offices in Atlanta, Boston and Phoenix employing over 200 staff. Craneware’s market-driven, SaaS solutions normalise disparate data sets, bringing in up-to-date regulatory and financial compliance data to deliver value at the points where clinical and operational data transform into financial transactions, creating actionable insights that enable informed tactical and strategic decisions. To learn more, visit craneware.com and thevaluecycle.com.
You might also like...
Aug 1, 2018 | Announcements
1 August 2018 - Craneware (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, is pleased to announce the appointment of Investec Bank plc as the Company's Joint Broker with immediate effect. Peel Hunt...read more
Jul 10, 2018 | Announcements
10 July 2018 - Craneware (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, provides an update on trading for the year ended 30 June 2018. The Group is pleased to announce continued outstanding...read more
Apr 17, 2018 | Announcements
Schedule 6, Block Admission Period to 15 April 2018 This block admission announcement, as required by the AIM Rules, is made every six months and relates to the number of shares that have been issued and allotted during this six month...read more